Form D/A — Mission BioCapital VI LP
0001470831-26-001005 · filed Nov 16, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1), Investment Company Act Section 3(c)(7)
- Reported offering amount
- —
- Reported amount sold
- $172,250,000
- Minimum investment
- $0
- Investors
- 15
- Sales commission
- $156,000
- Finders' fees
- $0
Issuer
- Name
- Mission BioCapital VI LP
- CIK
- 2039280
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- ONE MAIN STREET, SUITE 1100
CAMBRIDGE, Massachusetts 02142 - Phone
- 5085070934
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
General Partner Mission BioCapital VI GP LLC · PromoterCambridge, Massachusetts Find on LinkedIn ↗
-
Peter D. Parker · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗